1 The EIC Accelerator Project

The EIC Accelerator program, part of the European Innovation Council (EIC), is a key financial instrument designed to support innovative small and medium-sized enterprises (SMEs) with high growth potential in Europe. The program focuses on deep-tech and innovative startups, offering both grant funding and equity investments to help these companies scale and achieve market success.

Funding Structure

The EIC Accelerator provides blended finance, which combines grants and equity funding. The grant component can be as high as €2.5 million, intended to assist with early-stage development activities, such as technology development, prototyping, and testing. This funding is crucial for SMEs that often face challenges in securing initial financing.

In addition to the grant, the program offers equity investments, which can reach up to €15 million until 2024 and up to €10 million from 2025 onward. This equity funding is aimed at helping companies scale their operations, enter new markets, and attract further private investments. The potential for equity investment makes the EIC Accelerator particularly attractive, as it provides companies with the necessary capital to grow while maintaining a degree of financial support from the European Union.

Purpose and Impact in the Ecosystem

The EIC Accelerator plays a vital role in the European deep-tech and startup ecosystem by bridging the funding gap that often exists between initial seed funding and larger investments required for scaling. By providing substantial financial support, the program facilitates innovation, accelerates the commercialization of cutting-edge technologies, and fosters collaboration between startups and established corporations. This not only strengthens the European market but also enhances global competitiveness in high-tech sectors.

Role in Scaling and Private Sector Funding

The EIC Accelerator aims to ensure that successful applicants can leverage their funding to attract additional private sector financing. By providing a solid financial foundation, the program encourages startups to engage with venture capitalists and other investors, thereby facilitating further growth and development. The involvement of the EIC Accelerator helps build credibility, making companies more attractive to private investors.

EIC Accelerator Winner: MYSPHERA SL

Company Overview

MYSPHERA SL is a Spanish company recognized for its innovative contributions to the healthcare sector, particularly in optimizing patient pathways through advanced technology. The company focuses on developing solutions that improve healthcare efficiency and patient experiences.

Project Overview: PATHMAKER

The project funded under the EIC Accelerator is named PATHMAKER, which stands for an AI-Powered Visual Assistive Design IoT Pathway Platform. This platform aims to implement fast and optimal automated patient pathways and healthcare demand planning projects. The objective is to enhance the management of patient flow within healthcare settings, ensuring that resources are used effectively and that patients receive timely care.

Technology Background

The PATHMAKER platform leverages advanced artificial intelligence (AI) and Internet of Things (IoT) technologies. The fundamental premise is to create a system that can analyze real-time data from various sources, including patient records, hospital resources, and operational workflows. By integrating AI algorithms, the platform can predict patient demand, streamline processes, and suggest optimal pathways for patient care.

Key Features:

Impact on Healthcare

By implementing PATHMAKER, healthcare providers can optimize their operational efficiency, reduce waiting times, and enhance patient satisfaction. The project represents a significant advancement in the use of technology to meet the complex demands of modern healthcare systems.

In summary, the EIC Accelerator program is pivotal for supporting innovative companies like MYSPHERA SL. Through projects like PATHMAKER, it not only addresses critical challenges in healthcare but also fosters a more robust ecosystem for deep-tech innovation in Europe.

2 The Funding Rounds

MYSPHERA SL: Financing and Investment Overview Since EIC Accelerator Win

Company: MYSPHERA SL
Country: Spain
EIC Accelerator Submission Date: October 6, 2021

---

Financing Raised and Funding Rounds

MYSPHERA SL, a Spanish healthtech company founded in 2012 and based in Paterna, specializes in real-time location systems (RTLS) for healthcare process automation. The company has actively sought external funding to support its growth and technology development.

• Venture Round (2018): MYSPHERA received investment from Air Liquide’s venture arm ALIAD. While the specific amount is undisclosed in public records, this round reflects strategic interest from a leading industry player focused on healthcare innovation.
• Previous Funding Activity: Prior to the EIC Accelerator grant, the company had already raised capital through earlier rounds:
• A notable Series B round is attributed to another entity (Aveni), not directly linked to MYSPHERA. No evidence suggests that MYSPHERA completed a Series B or C as of April 2025.
• EIC Accelerator Grant (2021): Winning the EIC Accelerator provided non-dilutive funding—typically up to €2.5 million in grant support—for scaling innovative SMEs. This was secured after submitting their Step 2 proposal on October 6, 2021.

Timing and Amount of Funding Rounds

• 2018 Venture Round: Backed by ALIAD/Air Liquide; exact financial details remain confidential.
• October 2021: Awarded an EIC Accelerator grant after successful application.
• No publicly available data indicates additional equity financing or major venture rounds post-EIC win as of April 2025.

Investor Information

Key investors identified:

ALIAD (Air Liquide’s Venture Arm): Provided direct investment during the company's significant venture round in or before 2018.

No other prominent institutional investors are publicly associated with subsequent funding rounds since late 2021.

Company Valuations

There is no verified data on specific valuation figures for MYSPHERA SL following its receipt of EIC funding. As with many European private tech companies at this stage, valuations are typically disclosed only during significant equity events such as Series A/B/C financings or exits—which have not been reported for MYSPHERA since late 2021.

Exit Events: IPOs, Buyouts & Acquisitions

As of April 2025:

• No evidence exists that MYSPHERA has undergone an IPO.
• There are no public records indicating buyouts or acquisition activity involving the company.

The absence of such reports suggests that MYSPHERA remains privately held with ongoing operations focused on expanding its market presence within Europe and beyond through organic growth strategies supported by previous financing rounds and grants.

---

Summary Table: Key Financing Events Post-EIC Win

Event	Date	Amount	Investors	Notes
Venture Round	~2018	Undisclosed	ALIAD/Air Liquide	Strategic investment
EIC Accelerator	Oct. 6, 2021	Up to €2.5M	European Innovation Council	Non-dilutive grant

</em>Date refers to submission/cut-off; award typically follows successful Step 3 interview.

---

Sources

• MYSPHERA - Dealroom.co
• Air Liquide ALIAD - Teaserclub
• MYSHPERA Official Website
• MarketScreener - Pablo Enciso/MYSHPERA Network

3 The Press Releases

MYSPHERA SL, a Spanish company based in Valencia, has been advancing significantly since receiving the EIC Accelerator funding after submitting their Step 2 proposal in October 2021. The company specializes in real-time location systems (RTLS) and IoT solutions aimed at optimizing healthcare processes and patient flow in acute care hospitals.

Key Developments and Technology Advancements

• PATHMAKER Project: MYSPHERA developed PATHMAKER, an AI-powered visual assistive IoT pathway system that has notably reduced deployment times and enhanced scalability and flexibility of its healthcare solutions. They have secured intellectual property rights for PATHMAKER to protect its innovative elements, strengthening their competitive advantage.
• ORvital System: Originating from the EU-funded OR4.0 project, this patented RTLS solution uses Bluetooth technology to track patients throughout surgical processes, improving operating room efficiency by over 10%. It automates hospital workflows and provides real-time status updates to patients' relatives via an app or waiting room screens. This system is installed across multiple hospitals internationally.
• Artificial Intelligence Integration: In 2023, MYSPHERA further advanced AI applications within hospital process management by harnessing data collected from its systems to improve efficiency and patient care outcomes continually.

Partnerships and Market Expansion

• MYSPHERA has engaged in several European projects such as ActiveAge (focused on autonomy for seniors through IoT) and Operating Room 4.0 (to optimize surgical procedures using data analytics).
• Their strategic marketing campaign comprising over 35 significant actions online and offline has raised brand awareness globally.
• The company is preparing for a second venture capital round supported by the European Innovation Council (EIC), with sales forecasts reaching €40 million by 2028.

Team Updates & Leadership

Salvador Vera remains a key figure at MYSPHERA, reflecting publicly on the company's growth throughout recent years:

• In 2023 alone, around 400,000 patients used their systems.
• Their ORvital platform managed more than 150 thousand surgical operations across over 300 operating theatres.
• The newly launched Stela solution addressed Emergency Department waiting times benefiting more than 250 thousand patients within one year.

Vera expressed gratitude towards his team’s dedication as well as investors’ trust while emphasizing readiness to leverage new public investments such as Next Gen funds for further digitization of healthcare services.

Patents & Intellectual Property

MYSPHERA filed patents related to key components of their technologies like PATHMAKER’s intellectual property rights protection ensures long-term market positioning against competitors. No direct patent filings under the company's name were found outside these references but it is clear they prioritize securing IP around their innovations.

---

In summary, since winning EIC Accelerator funding in October 2021:

• MYSPHERA SL advanced its core RTLS technology combined with AI capabilities through projects like PATHMAKER.
• It expanded international presence with proven deployments improving surgical workflow efficiencies.
• Engaged actively with EU-funded projects enhancing digital health services integration.
• Successfully executed marketing strategies boosting visibility while preparing new investment rounds backed by strong growth outlooks.

These developments position MYSPHERA as a leading innovator transforming hospital process management toward smarter healthcare delivery.

Sources

MYSPHERA official website CORDIS report on PATHMAKER project MYSPHERA reflections on transformation during 2023 CORDIS article about OR4.0 / ORVital system Novobrief financing news about MYSPHERA SINTEC Partners profile on MYSPHERA

4 The Technology Advancements

MYSPHERA SL's Post-EIC Accelerator Advancements (2021–2024)

Current Capabilities

MYSPHERA SL, a Valencia-based healthcare technology company, specializes in Real-Time Location Systems (RTLS) and IoT-driven patient flow automation. Their solutions optimize hospital workflows in operating rooms (ORvital) and emergency departments (STELA), integrating Bluetooth-based tracking, AI analytics, and process automation to reduce idle time and improve resource allocation.

---

Technological Advancements Since EIC Accelerator Funding

The company secured EIC Accelerator funding for its PATHMAKER project, an AI-powered platform to design and deploy automated patient pathways. Key outcomes include:

• 50% faster deployment times for RTLS systems due to visual-assisted design tools.
• 15% improved surgical block capacity via the Demand Planner Designer module.
• Angle of Arrival (AoA) RTLS technology, achieving sub-meter precision for patient tracking.
• AI-driven descriptive analytics for data-informed decision-making in surgical scheduling and emergency department management.

---

Market Demonstrations & Customer Impact

MYSPHERA has expanded its market presence post-funding:

• ORvital adoption: Installed in over 500 operating rooms across five hospitals in four countries, increasing surgical throughput by >10% per site.
• STELA implementation: Enhanced emergency department efficiency through real-time task automation at multiple European hospitals.
• EIC-supported growth: Participation at MWC 2024 led to doubled sales via partnerships with Asian institutions and new hospital contracts.

---

Intellectual Property & Publications

While specific patents are not disclosed, MYSPHERA’s technology is described as proprietary across EU-funded projects like OR4.0 (now ORvital) and PATHMAKER[ˆ10], implying continued IP development. The company has contributed to academic discourse through collaborations with hospitals like Vall d’Hebron Barcelona but has not published standalone clinical trials or whitepapers directly cited in available materials. However, third-party reports highlight their impact: the Royal College of Physicians UK noted ORvital reduces hospital energy costs by 30% through optimized workflows[ˆ6].

---

Sources

5 The Partnerships and Customers

MYSPHERA SL Overview

MYSPHERA SL is a Spanish company based in Valencia, focused on transforming healthcare systems through real-time location systems (RTLS) and process automation. Since receiving EIC Accelerator funding in October 2021, MYSPHERA has continued to expand its presence and partnerships.

Partnerships and Customers

MYSPHERA has collaborated with several organizations:

• vCare Project: As a partner, MYSPHERA is involved in developing and commercializing location and workflow systems for acute care hospitals.
• LifeChamps Consortium: MYSPHERA is a technical partner in this consortium, which aims to implement leading-edge technologies across Europe.
• BEAMER Project: MYSPHERA is part of the BEAMER initiative under the Innovative Health Initiative, working alongside other SMEs and patient organizations.

New Partnerships and Customers

While specific new partnerships or customers are not detailed since the EIC funding, MYSPHERA's expansion plans suggest potential collaborations in Europe, North America, and Latin America. The company has a presence in over 50 healthcare centers across Spain, France, the UK, Chile, and Mexico.

Nature of New Relationships

New relationships for MYSPHERA likely involve strategic partnerships to enhance its RTLS and process automation solutions. These collaborations could focus on integrating AI and IoT technologies to improve patient flow and operational efficiency in healthcare settings.

Market Positioning

The new relationships will position MYSPHERA as a leader in healthcare technology, particularly in real-time patient flow solutions. By expanding its market reach and integrating advanced technologies like AI, MYSPHERA strengthens its competitive edge in the global healthcare sector.

Technology Advancements and Scaling

The relationships will facilitate technology advancements by leveraging AI and IoT innovations to enhance precision and efficiency in healthcare management. This will enable MYSPHERA to scale its operations more effectively, handling a greater number of projects with improved deployment times and scalability, as seen in the PATHMAKER project.

Sources

• MYSPHERA | Streamlining patient flow using RTLS
• Partners - vCare Project
• Consortium – LifeChamps
• Valencia's MYSPHERA Raises €2.5M to Expand IoT Health Services
• An AI-Powered Visual Assistive Design IoT Pathway
• The Digital Hospital: Moving towards efficient patient management
• BEAMER | IHI Innovative Health Initiative

6 The Hiring and Company Growth

MYSPHERA SL, a Spanish company specializing in healthcare technology, particularly in Real-Time Location Systems (RTLS) to streamline patient flow, received EIC Accelerator funding in October 2021. Here is an overview of the company's hiring, growth, and team developments:

Company Overview

MYSPHERA SL is located in Paterna, Valencia, Spain, and operates in the computer consultancy sector. The company focuses on automating and simplifying healthcare processes, especially in high-pressure departments like operating rooms and emergency departments.

Current Headcount

The company has between 10 and 49 employees, which suggests a relatively small but agile team structure.

Hiring Status

There is no specific information available on whether MYSPHERA SL is currently hiring. However, given its growth trajectory and the impact of EIC funding, it is plausible that they may be expanding their team to support new initiatives and projects.

Growth

Since receiving EIC Accelerator funding in October 2021, MYSPHERA SL has likely experienced growth in terms of project scope and technological development. The funding typically supports innovative projects, which can lead to increased headcount and team expansion over time. However, specific details about recent growth metrics are not publicly available.

Recent Hires

There is no public information about specific key positions recently filled by MYSPHERA SL. The company's focus on technology and healthcare suggests that any new hires would likely be in areas such as software development, healthcare consulting, or project management.

Impact of New Team Members

New team members would help MYSPHERA SL scale by contributing to the development and implementation of its RTLS solutions, enhancing customer support, and expanding its market reach. This growth would be crucial for enhancing the company's offerings in the healthcare sector and increasing its competitiveness.

Major Changes in Management

There is no available information regarding major changes in the management or founding team of MYSPHERA SL since receiving the EIC Accelerator funding.

Sources

• MYSPHERA | Streamlining patient flow using RTLS
• MYSPHERA SL. Company Profile
• MYSPHERA SL., PATERNA, (Spain), Verif
• MYSPHERA SL

7 The Media Features and Publications

MYSPHERA SL, a Spanish company specializing in healthcare technology, received the EIC Accelerator funding on October 6, 2021. Since then, the company has been actively involved in various initiatives to streamline patient flow in healthcare environments.

Media Features and Publications

While there are limited direct media mentions of MYSPHERA SL, the company has been recognized for its innovative healthcare solutions. For instance, the Royal College of Physicians in the UK noted that MYSPHERA's ORvital solution reduces energy costs by 30%. Additionally, MYSPHERA has published papers documenting its performance and effectiveness, which are available through scientific databases.

Content from Publications

Publications often focus on MYSPHERA's solutions for optimizing patient flow, particularly in operating rooms and emergency departments. The company's technology aims to automate and simplify complex healthcare processes, reducing idle time and improving coordination among healthcare professionals.

Podcasts or Interviews

There are no specific mentions of podcasts or interviews featuring the MYSPHERA SL team in the available search results.

Conference and Fair Visits

MYSPHERA SL has participated in several key conferences, including the European Healthcare Management Association Conference and HIMSS. These events have helped the company leverage significant private funding and expand its marketing efforts.

Involvement in Events

MYSPHERA has been involved in various events and initiatives, including marketing campaigns and academic presentations. The company's solutions have been showcased in international congresses, contributing to its growth and market visibility.

Sources

• MYSPHERA
• MYSPHERA Blog
• An AI-Powered Visual Assistive Design IoT Pathway
• Development of an intelligent and multi-hospital end-to-end solution